Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in Americans over 55 — and it often progresses silently before seniors notice anything is wrong. In 2026, an estimated 11 million Americans have AMD, and that number is projected to double by 2050. Understanding macular degeneration seniors 2026 — including its early warning signs, the critical difference between dry and wet AMD, and what Medicare will and won’t pay for — can be the difference between preserving your sight and losing it.
What Is Macular Degeneration in Seniors 2026?
The macula is the central portion of your retina — the tiny but mighty region responsible for sharp, detailed central vision used for reading, driving, recognizing faces, and watching television. AMD occurs when the macula deteriorates, causing central vision to blur, distort, or disappear entirely while peripheral vision remains intact.
There are two main types. Dry AMD accounts for 80–90% of all cases and progresses slowly over years. Wet AMD, while less common at 10–15%, can cause rapid and severe central vision loss within weeks or months if untreated. About 10–15% of dry AMD cases will eventually convert to wet AMD, which is why early monitoring is critical for everyone diagnosed with the dry form.
Risk Factors Every Senior Should Know
Your risk of developing macular degeneration seniors 2026 is shaped by several modifiable and non-modifiable factors:
| Risk Factor | Relative Risk Increase | Modifiable? |
|---|---|---|
| Age 75+ (vs under 64) | 6–7x higher risk | No |
| Smoking (current) | 2–3x higher risk | Yes — quitting reduces risk |
| Family history of AMD | 3–4x higher risk | No |
| Obesity (BMI 30+) | 2x higher risk | Yes |
| High blood pressure | 1.5–2x higher risk | Yes |
| UV light exposure (lifetime) | Moderate increase | Yes — protective sunglasses help |
| Western diet (high saturated fat) | Moderate increase | Yes |
Early Warning Signs of Macular Degeneration
One of the challenges of AMD is that early stages often produce no symptoms. By the time most seniors notice a problem, significant damage has already occurred. These are the warning signs that require immediate evaluation by an ophthalmologist:
- Blurry or fuzzy central vision — straight lines appear wavy or distorted
- Difficulty reading fine print — even with corrective lenses
- Dark spots or blind spots in the center of your visual field
- Colors appear washed out or less vivid than they used to
- Need for increasingly bright light when reading or doing close work
- Difficulty recognizing faces at a distance
- Wavy or curved appearance to straight lines (a specific sign of wet AMD)
Action step: Download the Amsler grid — a simple checkerboard test you can use at home weekly. If any lines appear wavy, bent, or absent when you cover one eye, call your eye doctor immediately. This is one of the earliest and most reliable home detection tools for wet AMD conversion.
Dry AMD: Progression Stages and What to Do
Dry AMD progresses through three stages. Understanding your stage determines both your monitoring schedule and which interventions can help:
- Early dry AMD: Several small or medium drusen (yellow deposits under the retina). No symptoms. Vision is normal. Annual monitoring recommended.
- Intermediate dry AMD: Many medium or one or more large drusen. Mild vision changes possible, especially in dim lighting. Every 6-month monitoring recommended. This is when AREDS2 supplements should be started.
- Late dry AMD (Geographic Atrophy): Breakdown of macula cells causes noticeable central vision loss. Recent FDA approvals in 2023 (pegcetacoplan/Syfovre and avacincaptad pegol/Izervay) offer the first treatments to slow geographic atrophy progression.
AREDS2 Supplements: What the Evidence Shows
The Age-Related Eye Disease Study 2 (AREDS2), sponsored by the National Eye Institute, remains the gold standard for AMD supplement guidance. For people with intermediate or advanced AMD in one eye, the AREDS2 formula reduced the risk of progression to advanced AMD by 25% over 5 years.
The evidence-backed AREDS2 formula contains: Vitamin C 500 mg, Vitamin E 400 IU, Zinc 80 mg (as zinc oxide), Copper 2 mg (as cupric oxide), Lutein 10 mg, and Zeaxanthin 2 mg. The updated formula removed beta-carotene (which increased lung cancer risk in smokers) and added lutein and zeaxanthin. These supplements are available over-the-counter under brand names like PreserVision AREDS2. Medicare does not cover supplements, but they cost approximately $25–45 per month.
Wet AMD Treatment 2026: Anti-VEGF Injections Explained
Wet AMD is treated with anti-VEGF (vascular endothelial growth factor) injections that stop the growth of abnormal blood vessels under the retina. These are among the most important medical advances in ophthalmology of the past 20 years. Current FDA-approved options include:
- Ranibizumab (Lucentis) — original standard; monthly injections; Part B covered
- Bevacizumab (Avastin) — off-label but widely used; lowest cost; Part B covered
- Aflibercept (Eylea) — less frequent dosing (every 8 weeks after initiation); Part B covered; generic available 2026
- Faricimab (Vabysmo) — newest dual-action agent; can extend to every 16 weeks in some patients; Part B covered
- High-dose aflibercept (Eylea HD) — FDA approved 2023; extended dosing to every 12–16 weeks
The critical message: with prompt treatment, most wet AMD patients can stabilize and some regain partial vision. Without treatment, wet AMD causes legal blindness within 2 years in the majority of untreated patients.
Does Medicare Cover Macular Degeneration Treatment in 2026?
Medicare coverage for macular degeneration seniors 2026 depends on the type of treatment:
| Service | Medicare Coverage | Your Cost (after $283 deductible) |
|---|---|---|
| Anti-VEGF injections (Eylea, Lucentis, Vabysmo) | Part B — 80% | 20% coinsurance (~$100–400/injection) |
| Photodynamic therapy (PDT) | Part B — 80% | 20% coinsurance |
| Laser surgery for abnormal vessels | Part B — 80% | 20% coinsurance |
| Diagnostic eye exams (AMD-related) | Part B — 80% | 20% coinsurance |
| OCT imaging (diagnostic) | Part B — 80% | 20% coinsurance |
| Routine eye exams (glasses, contacts) | NOT covered by Original Medicare | Full cost out-of-pocket |
| AREDS2 supplements | NOT covered | Full cost (~$25–45/month) |
If you have a Medigap Plan G or Plan N, the 20% coinsurance on anti-VEGF injections (which can cost $2,000–$4,500 per dose without insurance) is covered by your supplement. For seniors receiving monthly injections, this coverage can mean thousands of dollars in annual savings.
5 Proven Steps to Protect Your Vision from AMD
- Get a dilated eye exam annually: After age 60, ask your doctor for a comprehensive dilated eye exam every year. This is the only way to catch early AMD before symptoms develop.
- Quit smoking immediately: Smoking doubles to triples AMD risk and accelerates progression. This is the single most impactful lifestyle change.
- Follow the AREDS2 diet: High lutein intake (kale, spinach, eggs), omega-3 fatty acids (salmon, sardines), and reduced saturated fat all independently support macular health.
- Wear UV-protective sunglasses: Choose glasses that block 99–100% of UVA and UVB rays when outdoors.
- Control blood pressure and body weight: Hypertension accelerates small blood vessel damage in the eye. Managing it reduces AMD progression risk.
Sources
- Medicare.gov — Macular Degeneration Tests and Treatment Coverage
- National Eye Institute — Age-Related Macular Degeneration
- AARP — What You Need to Know About Macular Degeneration
Related Articles You May Find Helpful
- Eye Floaters and Flashes in Seniors 2026: When to See a Doctor Immediately
- Cataracts in Seniors 2026: Warning Signs, Surgery & Medicare Coverage
- Glaucoma in Seniors 2026: Free Medicare Screenings & Treatment Guide
- Medicare Annual Wellness Visit 2026: Free Benefits Most Seniors Miss
- Best Medigap Plans 2026: Which Medicare Supplement Saves Most?
